157. スタージ・ウェーバー症候群 Sturge-Weber syndrome Clinical trials / Disease details

臨床試験数 : 10 / 薬物数 : 14 - (DrugBank : 4) / 標的遺伝子数 : 5 - 標的パスウェイ数 : 63

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04447846 (ClinicalTrials.gov)	October 14, 2019	10/10/2019	Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome	Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome: A Phase II Trial	Sturge-Weber Syndrome	Drug: Cannabidiol	Anne Comi, MD	Jazz Pharmaceuticals;Faneca 66 Foundation	Completed	3 Years	50 Years	All	10	Phase 2	United States
2	NCT02332655 (ClinicalTrials.gov)	December 2014	5/1/2015	Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber Syndrome	Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber Syndrome	Sturge-Weber Syndrome	Drug: Cannabidiol	Anne Comi, MD	GW Pharmaceuticals Ltd.;Faneca 66 Foundation	Active, not recruiting	1 Month	45 Years	All	5	Phase 1/Phase 2	United States